| 1 |
David B. Bowler |
Arris Enterprises |
7 |
| 2 |
David J. Lauffer |
Vertex Pharmaceuticals Incorporated |
4 |
| 3 |
Andrew Goldman |
Formlabs |
3 |
| 3 |
Christopher Buck |
Lutron Electronics Co. |
3 |
| #5 |
Torsten Herbertz |
Forma Therapeutics |
2 |
| #5 |
Kristen Dodds Weight |
Rai Strategic Holdings |
2 |
| #5 |
Daniel R. Getts |
Northwestern University |
2 |
| #5 |
Gary Hattersley |
Genetics Institute |
2 |
| #5 |
Adam Patrick Joyce |
Inari Agriculture Technology |
2 |
| #5 |
Tony Fleming |
Novartis Ag |
2 |
| #5 |
Simon P. Robinson |
Lantheus Medical Imaging |
2 |
| #5 |
David S. Millan |
Forma Therapeutics |
2 |
| #5 |
Thomas Gero |
Nbd Nanotechnologies |
2 |
| #14 |
Brian M. Perreault |
Magnemotion |
1 |
| #14 |
David Schoon |
Schoonscan |
1 |
| #14 |
Susan Egan |
Bristol-Myers Squibb |
1 |
| #14 |
Jian L. Ding |
Saint-Gobain Performance Plastics |
1 |
| #14 |
Danna M. Breen |
Pfizer |
1 |
| #14 |
Jesus N. Abelarde, Jr. |
The Mitre |
1 |
| #14 |
Louis Scott Hills |
Aware |
1 |
| #14 |
Paul Rotker |
Digital Equipment |
1 |
| #14 |
Derek P. Rocca |
RTX (Raytheon) |
1 |
| #14 |
Kenneth Allen Rogers |
IBM |
1 |
| #14 |
Michael H. J. Rhodin |
Enanta Pharmaceuticals |
1 |
| #14 |
Allen Hadden |
Emc |
1 |
| #14 |
Christopher DeMaria |
Eli Lilly |
1 |
| #14 |
Atli Thorarensen |
Pfizer |
1 |
| #14 |
Richard C. Wehrle |
Monster Worldwide |
1 |
| #14 |
James Neef |
Novartis Ag |
1 |
| #14 |
Marvin A. Guiles |
Medline Industries, Lp |
1 |
| #14 |
Christian Matranga |
Greenlight Biosciences |
1 |
| #14 |
Edward D. Kingsley |
Performance Indicator |
1 |
| #14 |
John SUBASIC |
Boston Scientific Scimed |
1 |
| #14 |
Danh H. Nguyen |
Drexel University |
1 |
| #14 |
Pam Weathers |
Arkansas State University—Jonesboro |
1 |
| #14 |
Md Tamzeed Islam |
Amazon |
1 |
| #14 |
Michael C. Naill |
Dragonfly Therapeutics |
1 |
| #14 |
Chris DE SAVI |
Forward Therapeutics |
1 |
| #14 |
Jennifer Stroka Cobb |
Novartis Ag |
1 |
| #14 |
Kevin John Trenholme |
Amazon |
1 |